JP2023504003A5
(cg-RX-API-DMAC7.html )
2023-12-04
US20250034273A1
(en )
2025-01-30
Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof
JP2025102836A5
(cg-RX-API-DMAC7.html )
2025-10-30
IL293241A
(en )
2022-07-01
Bispecific antibody, anti-1-pd, anti-vegfa, pharmaceutical preparation containing it and its use
JP2022515318A5
(cg-RX-API-DMAC7.html )
2023-07-28
JP2021524249A5
(cg-RX-API-DMAC7.html )
2022-05-25
JP2021525082A5
(cg-RX-API-DMAC7.html )
2022-05-31
JP2020501531A5
(cg-RX-API-DMAC7.html )
2020-12-17
JP2019500892A5
(cg-RX-API-DMAC7.html )
2020-02-06
RU2017145150A
(ru )
2019-06-21
Антитело против pdl-1, его фармацевтическая композиция и применение
JP2020534351A5
(cg-RX-API-DMAC7.html )
2021-10-07
JP2022525071A5
(cg-RX-API-DMAC7.html )
2023-03-24
JP2026041845A5
(cg-RX-API-DMAC7.html )
2026-04-21
JP2023543152A5
(cg-RX-API-DMAC7.html )
2025-09-30
JP2024509018A5
(cg-RX-API-DMAC7.html )
2025-03-26
JP2022512642A5
(cg-RX-API-DMAC7.html )
2022-10-18
JP2025504496A5
(cg-RX-API-DMAC7.html )
2026-01-06
JP2023518153A5
(cg-RX-API-DMAC7.html )
2023-06-12
JP2024538669A5
(cg-RX-API-DMAC7.html )
2025-10-07
JP2024540148A5
(cg-RX-API-DMAC7.html )
2025-11-12
JP2024515396A5
(cg-RX-API-DMAC7.html )
2025-02-28
JP2025507817A5
(cg-RX-API-DMAC7.html )
2026-02-25
JP2021515542A5
(cg-RX-API-DMAC7.html )
2022-03-15
JP2024525916A5
(cg-RX-API-DMAC7.html )
2025-07-22
JP2023517754A5
(cg-RX-API-DMAC7.html )
2024-03-18